Literature DB >> 30332908

Superior cellular activities of azido- over amino-functionalized ligands for engineered preQ1 riboswitches in E.coli.

Eva Neuner1, Marina Frener1, Alexandra Lusser2, Ronald Micura1.   

Abstract

For this study, we utilized class-I and class-II preQ1-sensing riboswitches as model systems to decipher the structure-activity relationship of rationally designed ligand derivatives in vitro and in vivo. We found that synthetic preQ1 ligands with amino-modified side chains that protrude from the ligand-encapsulating binding pocket, and thereby potentially interact with the phosphate backbone in their protonated form, retain or even increase binding affinity for the riboswitches in vitro. They, however, led to significantly lower riboswitch activities in a reporter system in vivo in E. coli. Importantly, when we substituted the amino- by azido-modified side chains, the cellular activities of the ligands were restored for the class-I conditional gene expression system and even improved for the class-II counterpart. Kinetic analysis of ligand binding in vitro revealed enhanced on-rates for amino-modified derivatives while they were attenuated for azido-modified variants. This shows that neither high affinities nor fast on-rates are necessarily translated into efficient cellular activities. Taken together, our comprehensive study interconnects in vitro kinetics and in vitro thermodynamics of RNA-ligand binding with the ligands' in vivo performance and thereby encourages azido- rather than amino-functionalized design for enhanced cellular activity.

Entities:  

Keywords:  RNA biosensor tools; RNA ligand recognition; kinetics; modifications; preQ1 derivatives; riboswitches; thermodynamics

Mesh:

Substances:

Year:  2018        PMID: 30332908      PMCID: PMC6284575          DOI: 10.1080/15476286.2018.1534526

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  51 in total

1.  Mg(2+) shifts ligand-mediated folding of a riboswitch from induced-fit to conformational selection.

Authors:  Krishna C Suddala; Jiarui Wang; Qian Hou; Nils G Walter
Journal:  J Am Chem Soc       Date:  2015-10-29       Impact factor: 15.419

2.  Tuning a riboswitch response through structural extension of a pseudoknot.

Authors:  Marie F Soulière; Roger B Altman; Veronika Schwarz; Andrea Haller; Scott C Blanchard; Ronald Micura
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

Review 3.  The promise of riboswitches as potential antibacterial drug targets.

Authors:  Christina E Lünse; Anna Schüller; Günter Mayer
Journal:  Int J Med Microbiol       Date:  2013-09-04       Impact factor: 3.473

4.  Single-molecule FRET studies on the cotranscriptional folding of a thiamine pyrophosphate riboswitch.

Authors:  Heesoo Uhm; Wooyoung Kang; Kook Sun Ha; Changwon Kang; Sungchul Hohng
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-26       Impact factor: 11.205

5.  Novel riboswitch-binding flavin analog that protects mice against Clostridium difficile infection without inhibiting cecal flora.

Authors:  Kenneth F Blount; Cynthia Megyola; Mark Plummer; David Osterman; Tim O'Connell; Paul Aristoff; Cheryl Quinn; R Alan Chrusciel; Toni J Poel; Heinrich J Schostarez; Catherine A Stewart; Daniel P Walker; Peter G M Wuts; Ronald R Breaker
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

Review 6.  A switch in time: detailing the life of a riboswitch.

Authors:  Andrew D Garst; Robert T Batey
Journal:  Biochim Biophys Acta       Date:  2009-07-09

Review 7.  A decade of riboswitches.

Authors:  Alexander Serganov; Evgeny Nudler
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

8.  Three-dimensional structure of hyper-modified nucleoside Q located in the wobbling position of tRNA.

Authors:  S Yokoyama; T Miyazawa; Y Iitaka; Z Yamaizumi; H Kasai; S Nishimura
Journal:  Nature       Date:  1979-11-01       Impact factor: 49.962

9.  Isolation and characterization of an Escherichia coli mutant lacking tRNA-guanine transglycosylase. Function and biosynthesis of queuosine in tRNA.

Authors:  S Noguchi; Y Nishimura; Y Hirota; S Nishimura
Journal:  J Biol Chem       Date:  1982-06-10       Impact factor: 5.157

10.  Single transcriptional and translational preQ1 riboswitches adopt similar pre-folded ensembles that follow distinct folding pathways into the same ligand-bound structure.

Authors:  Krishna C Suddala; Arlie J Rinaldi; Jun Feng; Anthony M Mustoe; Catherine D Eichhorn; Joseph A Liberman; Joseph E Wedekind; Hashim M Al-Hashimi; Charles L Brooks; Nils G Walter
Journal:  Nucleic Acids Res       Date:  2013-09-03       Impact factor: 16.971

View more
  5 in total

1.  Nucleobase mutants of a bacterial preQ1-II riboswitch that uncouple metabolite sensing from gene regulation.

Authors:  Debapratim Dutta; Joseph E Wedekind
Journal:  J Biol Chem       Date:  2019-10-28       Impact factor: 5.157

Review 2.  Unraveling the structure and biological functions of RNA triple helices.

Authors:  Jessica A Brown
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-05-22       Impact factor: 9.957

3.  Changed reactivity of secondary hydroxy groups in C8-modified adenosine - lessons learned from silylation.

Authors:  Jennifer Frommer; Sabine Müller
Journal:  Beilstein J Org Chem       Date:  2020-11-23       Impact factor: 2.883

4.  A small RNA that cooperatively senses two stacked metabolites in one pocket for gene control.

Authors:  Griffin M Schroeder; Chapin E Cavender; Maya E Blau; Jermaine L Jenkins; David H Mathews; Joseph E Wedekind
Journal:  Nat Commun       Date:  2022-01-11       Impact factor: 17.694

5.  Functional integration of a semi-synthetic azido-queuosine derivative into translation and a tRNA modification circuit.

Authors:  Larissa Bessler; Navpreet Kaur; Lea-Marie Vogt; Laurin Flemmich; Carmen Siebenaller; Marie-Luise Winz; Francesca Tuorto; Ronald Micura; Ann E Ehrenhofer-Murray; Mark Helm
Journal:  Nucleic Acids Res       Date:  2022-10-14       Impact factor: 19.160

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.